Primary Care Workup for Elderly Patients Reporting Memory Changes

Initial Clinical Assessment

The American Academy of Family Physicians recommends that primary care providers remain vigilant for multiple presentations that signal potential cognitive disorders, not just direct memory complaints, including functional decline indicators, behavioral changes, and work and social difficulties 1
Functional decline indicators, such as unexplained decline in instrumental activities of daily living, missed appointments, difficulty managing medications, decreased self-care, and victimization by financial scams, should be identified 1, 2
Behavioral changes, including new-onset late-life depression or anxiety, personality changes, and abandonment of hobbies or interests, should be assessed 1, 3

The Alzheimer's Association recommends using brief validated instruments, such as the Mini-Cog, Memory Impairment Screen (MIS) + Clock Drawing Test, Four-item MoCA, and GPCOG, for rapid screening of cognitive impairment 1, 5
The American Geriatrics Society recommends using more sensitive instruments, such as the Montreal Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE), and Modified Mini-Mental State (3MS) or RUDAS, for comprehensive screening 1, 5

The American College of Physicians recommends performing targeted laboratory workup to identify treatable conditions, including complete blood count with differential, comprehensive metabolic panel, thyroid function tests, and vitamin B12, folate, and homocysteine levels 2, 8

The American Geriatrics Society recommends compiling a complete medication list and identifying anticholinergic medications, potentially inappropriate medications, and drug interactions that may contribute to cognitive symptoms 2, 8

The American Academy of Neurology recommends anatomical neuroimaging, such as MRI or CT, when there is a recent onset of cognitive symptoms, unexpected decline in cognition or function, recent significant head trauma, or unexplained neurological manifestations 2, 7

The National Institute on Aging recommends distinguishing between subjective cognitive decline (SCD), mild cognitive impairment (MCI), and dementia based on cognitive symptoms and functional impairment 1, 7

The American Academy of Family Physicians recommends providing reassurance and follow-up for patients with negative corroborative history and normal testing, and referring patients with MCI or dementia to a specialist for further evaluation and treatment 4, 7

The American Heart Association recommends prioritizing proactive assessment in patients with elevated risk, including history of stroke or TIA, late-onset depressive disorder, untreated sleep apnea, unstable metabolic or cardiovascular morbidity, and recent episode of delirium 1, 3

The Alzheimer's Association recommends that blood-based biomarkers should not be used for primary care screening, but rather in specialist clinics with results confirmed by CSF or PET 9